Viewing Study NCT06027567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-01-25 @ 10:33 PM
Study NCT ID: NCT06027567
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-06
First Post: 2023-02-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Effect of an Anti-obesity Drug, Semaglutide, As Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (dietician) with Regards to Change in Weight and Intracranial Pressure
Sponsor: Rigmor Højland Jensen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Idiopathic Intracranial Hypertension View
None Intracranial Pressure View
None Obesity View
None Pseudotumor Cerebri Syndrome View
None Papilledema View
None Weight Loss View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Idiopathic Intracranial Hypertension View
None Papilledema View
None Weight loss View
None Obesity View
None Pseudotumor Cerebri Syndrome View
None Intracranial Pressure View